Article Correctness Is Author's Responsibility: Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS

The article below may contain offensive and/or incorrect content.

In patients with relapse-remitting multiple sclerosis, the initiation of oral disease-modifying therapies is associated with a lower relapse risk as well as a lower risk for disability progression.